Overview
PT-141, commonly known as Bremelanotide, is a synthetic cyclic peptide of the melanocortin agonist class, derived from melanocortin-related peptide structures. Its research profile centers on affinity for the MC3R and MC4R receptor subtypes and the central nervous system signaling pathways these receptors mediate, making it a frequent tool in receptor pharmacology and melanocortin system biology.
Mechanism of Action
PT-141 functions as a melanocortin receptor agonist with demonstrated binding at MC3R and MC4R. Activation of these receptors initiates intracellular signaling cascades associated with melanocortin pathway regulation in CNS-focused laboratory models. Its selectivity profile — engaging MC3R/MC4R rather than the peripheral MC1R target preferred by α-MSH — allows researchers to isolate central melanocortin signaling from peripheral pigmentation-pathway activity.
Specifications
- Purity: ≥99% (HPLC) with mass-spectrometry identity confirmation
- Form: Lyophilized powder
- CAS Number: 189691-06-3
- Molecular Weight: ~1025.2 g/mol
- Chemical Formula: C₅₀H₆₈N₁₄O₁₀
- Synonyms: Bremelanotide, PT141, Melanotan II analog
Research Applications
- MC3R and MC4R receptor characterization
- Melanocortin receptor binding studies
- CNS signaling investigations
- Ligand pharmacology and pathway analysis
- Comparative melanocortin agonist research





